Calidi Biotherapeutics, Inc., a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease. The company offers CLD-101, which is in Phase 1b/2 clinical trial for the treatment of newly diagnos...
Leadership
Eric E. Poma Ph.D.
CEO & Director
Andrew C. Jackson
CFO & Corporate Secretary
Antonio Fernandez Santidrian Ph.D., Pharm.D.
Head of Technical Operations & Chief Scientific Officer
